(NYSE: AORT) Artivion's forecast annual revenue growth rate of 10.33% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.56%.
Artivion's revenue in 2025 is $390,084,000.On average, 2 Wall Street analysts forecast AORT's revenue for 2025 to be $18,330,170,461, with the lowest AORT revenue forecast at $18,319,494,765, and the highest AORT revenue forecast at $18,340,846,158. On average, 2 Wall Street analysts forecast AORT's revenue for 2026 to be $20,132,227,988, with the lowest AORT revenue forecast at $20,091,660,343, and the highest AORT revenue forecast at $20,172,795,634.
In 2027, AORT is forecast to generate $22,444,583,796 in revenue, with the lowest revenue forecast at $22,444,583,796 and the highest revenue forecast at $22,444,583,796.